The European Union's healthcare regulator on Wednesday said there currently is no evidence which links anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19.
The EMA's announcement follows a similar tone on Monday from Nurofen producer Reckitt Benckiser to check reports that said the pills' active ingredient ibuprofen would hurt patients.
The BIST name and logo are protected under the "Protected Trademark Certificate" and cannot be used, quoted, or altered without permission.All rights to the information disclosed under the BIST name are entirely owned by BIST and cannot be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.